Research Article
NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer
Figure 9
NAV3 promoted CRC cell proliferation in vitro. (a) NAV3 expressions in five CRC cells examined via RT-qPCR. (b) The efficiency of NAV3 silencing was examined through RT-qPCR in the HCT116 and SW480 after the transfection with siRNAs. (c) CCK-8 experiments confirming that silencing of NAV3 inhibited the proliferation of HCT116 and SW480 cells. .
(a) |
(b) |
(c) |